Maddy summaryS 1528, the Disaster Assistance Simplification Act, creates a single unified application system for disaster survivors to access all federal disaster assistance programs (like housing aid, small business loans, and food benefits) through one online form instead of multiple separate applications. It streamlines data sharing between federal, state, tribal, and local agencies by waiving certain paperwork rules during disasters and requiring standardized data security and privacy protections for applicant information. The bill directly affects disaster survivors seeking aid, FEMA, and all federal agencies providing disaster assistance by reducing bureaucratic delays and duplicate paperwork. Key provisions include a 360-day deadline for FEMA to establish the system, automatic consent for data sharing via online applications, and mandatory security certifications to protect personal details.
Sponsored bills
Maddy summaryThis bill prohibits law enforcement and intelligence agencies from purchasing personal data from third-party data brokers, including location information, communication contents, and online activity records. It defines "covered records" as information about people inside the U.S. or U.S. persons outside the U.S., and requires government requests for such information to follow the same legal standards as requests from telecommunications providers. The bill prohibits using illegally obtained information as evidence in court and establishes that the Foreign Intelligence Surveillance Act is the exclusive legal process for collecting certain types of data for foreign intelligence purposes. It also prevents agencies from sharing information obtained through improper means with other government entities.
Maddy summaryS 2602, the "Limiting CDC to Disease Control Act," narrows the Centers for Disease Control and Prevention's (CDC) regulatory authority under federal law. It amends Section 361(a) of the Public Health Service Act to restrict the CDC's ability to issue regulations solely to two specific areas: (1) measures already authorized under existing subsections (b) through (d), and (2) inspections, fumigation, or sanitation for infected sources. This directly affects the CDC and the Department of Health and Human Services (HHS), limiting their power to create new disease control regulations beyond these defined methods. The bill does not change existing disease control powers but explicitly restricts future regulatory scope to these two narrow provisions.
Maddy summaryThis bill establishes a new Office of the Special Inspector General for Ukraine Aid to oversee military, economic, and humanitarian assistance provided to Ukraine. The Special Inspector General will conduct independent audits and investigations of how these funds are used, including tracking expenditures, monitoring contracts, and preventing waste or fraud. The office must submit quarterly reports to Congress detailing all obligations, expenditures, and revenues related to Ukraine aid, with reports published in English, Ukrainian, and Russian. The oversight office will operate until September 30, 2027, when it will terminate with a final forensic audit report.
Maddy summaryThis bill amends the Federal Food, Drug, and Cosmetic Act to clarify the regulation of hemp-derived products. It removes hemp, hemp-derived cannabidiol (CBD), and related substances from the definition of "dietary supplements," excluding them from current supplement regulations. The bill also defines "hemp" per the Agricultural Marketing Act and grants the Secretary of Health and Human Services authority to establish labeling requirements and enforce rules for products containing these substances. This directly affects businesses selling hemp-based supplements and food products, as well as consumers purchasing them, by changing how these items are regulated under federal food safety laws.
Maddy summaryThis bill, the Free Speech Protection Act, prohibits federal employees from directing or pressuring social media platforms to censor protected speech or label content as misinformation. It bans government requests for user data related to specific topics and requires agencies to report all communications with platforms about content moderation. Violations would result in penalties including fines, job loss, and bans from government contracts. The bill also terminates the Disinformation Governance Board and prohibits government grants related to labeling content as misinformation. Affected individuals can sue government agencies and employees for violations.
Maddy summaryThe WATCH Act requires foreign laboratories receiving U.S. federal funds for animal research to undergo quarterly inspections to ensure compliance with U.S. animal welfare standards. It directly affects overseas labs conducting NIH-funded studies involving animals, mandating regular checks of their animal care committees, treatment reviews, and record-keeping. Labs must maintain certification of compliance, with public access to these certificates, and face potential suspension of funding if they fail to correct violations after a warning. The bill establishes a process for U.S. authorities to coordinate inspections with foreign governments while upholding U.S. research standards.
Maddy summaryThe Medicare Audiology Access Improvement Act of 2023 would expand Medicare coverage to include audiology services provided directly by qualified audiologists without requiring a physician referral, supervision, or that the patient be under a physician's care. Starting January 1, 2025, Medicare would cover hearing and balance assessments and treatments that audiologists are legally permitted to perform under state law, with payment set at 80% of the cost. This change would improve access to hearing care for Medicare beneficiaries and allow audiologists to practice more independently under Medicare. The bill does not alter the existing scope of covered services beyond what was available as of December 31, 2024.
Maddy summaryThis bill changes how biosimilar drugs are approved by automatically considering them interchangeable with brand-name drugs, removing a previous requirement for separate approval. It requires the FDA to brief congressional health committees before demanding certain safety studies on switching between biosimilars and reference drugs. The law affects drug manufacturers seeking FDA approval for biosimilars and the FDA itself. These changes apply only to new applications approved after the bill's enactment.
Maddy summaryThe Federal Prisons Accountability Act of 2023 would require the President to appoint the Director of the Bureau of Prisons with the advice and consent of the Senate, replacing the current system where the Director is appointed by the Attorney General. It also establishes a 10-year term for the Director, with the current Director permitted to continue serving until three months after the bill’s enactment. This change directly affects the leadership of the federal prison system, which manages 122 facilities and oversees over 159,000 inmates and 34,000 employees. The bill aligns the appointment process for the Bureau of Prisons Director with other senior Justice Department positions that require Senate confirmation.